GT Biopharma (OXIA.F) Q3 2026 Earnings

12AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.71
-0.5
-0.28
-0.07

Details

Expected EPS
-0.069136
Actual EPS
N/A
Surprise EPS
0.07
Surprise Percent
+100%

Description

GT Biopharma (OXIA.F) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts